137 related articles for article (PubMed ID: 38536666)
1. Non-cancerous complications in HTLV-1 carriers.
Ohmoto A; Fuji S
Expert Rev Anti Infect Ther; 2024 May; 22(5):307-316. PubMed ID: 38536666
[TBL] [Abstract][Full Text] [Related]
2. Systemic diseases in patients with HTLV-1-associated uveitis.
Nakao K; Abematsu N; Sakamoto T
Br J Ophthalmol; 2018 Mar; 102(3):373-376. PubMed ID: 28689168
[TBL] [Abstract][Full Text] [Related]
3. Early Onset of HTLV-1 Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP) and Adult T-cell Leukemia/Lymphoma (ATL): Systematic Search and Review.
Oliveira PD; Kachimarek AC; Bittencourt AL
J Trop Pediatr; 2018 Apr; 64(2):151-161. PubMed ID: 28582585
[TBL] [Abstract][Full Text] [Related]
4. Incidence of human T cell lymphotropic virus type 1-associated myelopathy/tropical spastic paraparesis in a long-term prospective cohort study of initially asymptomatic individuals in Brazil.
Romanelli LC; Caramelli P; Martins ML; Gonçalves DU; Proietti FA; Ribas JG; Araújo MG; Carneiro-Proietti AB
AIDS Res Hum Retroviruses; 2013 Sep; 29(9):1199-202. PubMed ID: 23617363
[TBL] [Abstract][Full Text] [Related]
5. HTLV-I serostatus of mothers of patients with adult T-cell leukemia and HTLV-I-associated myelopathy/tropical spastic paraparesis.
Bartholomew C; Jack N; Edwards J; Charles W; Corbin D; Cleghorn FR; Blattner WA
J Hum Virol; 1998; 1(4):302-5. PubMed ID: 10195256
[TBL] [Abstract][Full Text] [Related]
6. Programmed death-1 (PD-1)/PD-1 ligand pathway-mediated immune responses against human T-lymphotropic virus type 1 (HTLV-1) in HTLV-1-associated myelopathy/tropical spastic paraparesis and carriers with autoimmune disorders.
Kozako T; Yoshimitsu M; Akimoto M; White Y; Matsushita K; Soeda S; Shimeno H; Kubota R; Izumo S; Arima N
Hum Immunol; 2011 Nov; 72(11):1001-6. PubMed ID: 21851845
[TBL] [Abstract][Full Text] [Related]
7. Target epitopes of HTLV-1 recognized by class I MHC-restricted cytotoxic T lymphocytes in patients with myelopathy and spastic paraparesis and infected patients with autoimmune disorders.
Kozako T; Akimoto M; Toji S; White Y; Suzuki S; Arima T; Suruga Y; Matsushita K; Shimeno H; Soeda S; Kubota R; Izumo S; Uozumi K; Arima N
J Med Virol; 2011 Mar; 83(3):501-9. PubMed ID: 21264872
[TBL] [Abstract][Full Text] [Related]
8. Tropical spastic paraparesis and HTLV-1 associated myelopathy: clinical, epidemiological, virological and therapeutic aspects.
Gessain A; Mahieux R
Rev Neurol (Paris); 2012 Mar; 168(3):257-69. PubMed ID: 22405461
[TBL] [Abstract][Full Text] [Related]
9. An altered maturation and adhesion phenotype of dendritic cells in diseased individuals compared to asymptomatic carriers of human T cell leukemia virus type 1.
Manuel SL; Sehgal M; Khan ZK; Goedert JJ; Betts MR; Jain P
AIDS Res Hum Retroviruses; 2013 Sep; 29(9):1273-85. PubMed ID: 23750452
[TBL] [Abstract][Full Text] [Related]
10. HTLV-1: A real pathogen or a runaway guest of a diseased cell?
Kanzaki LIB
J Biosci; 2018 Sep; 43(4):785-795. PubMed ID: 30207322
[TBL] [Abstract][Full Text] [Related]
11. Human T-lymphotropic virus 1 (HTLV-1)-associated lichenoid dermatitis induced by CD8+ T cells in HTLV-1 carrier, HTLV-1-associated myelopathy/tropical spastic paraparesis and adult T-cell leukemia/lymphoma.
Tokura Y; Ito T; Kawakami C; Sugita K; Kasuya A; Tatsuno K; Sawada Y; Nakamura M; Shimauchi T
J Dermatol; 2015 Oct; 42(10):967-74. PubMed ID: 26077665
[TBL] [Abstract][Full Text] [Related]
12. Risk factors and cofactors for human T-cell lymphotropic virus type I (HTLV-I)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) in Jamaica.
Krämer A; Maloney EM; Morgan OS; Rodgers-Johnson P; Manns A; Murphy EL; Larsen S; Cranston B; Murphy J; Benichou J
Am J Epidemiol; 1995 Dec; 142(11):1212-20. PubMed ID: 7485068
[TBL] [Abstract][Full Text] [Related]
13. Effect of HTLV-1 Infection on the Clinical Course of Patients with Rheumatoid Arthritis.
Umekita K
Viruses; 2022 Jul; 14(7):. PubMed ID: 35891440
[TBL] [Abstract][Full Text] [Related]
14. Frequency of p12K and p12R alleles of HTLV Type 1 in HAM/TSP patients and in asymptomatic HTLV type 1 carriers.
Martins ML; Soares BC; Ribas JG; Thorun GW; Johnson J; Kroon EG; Carneiro-Prioetti AB; Bonjardim CA;
AIDS Res Hum Retroviruses; 2002 Sep; 18(13):899-902. PubMed ID: 12230932
[TBL] [Abstract][Full Text] [Related]
15. In vivo expression of the HBZ gene of HTLV-1 correlates with proviral load, inflammatory markers and disease severity in HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP).
Saito M; Matsuzaki T; Satou Y; Yasunaga J; Saito K; Arimura K; Matsuoka M; Ohara Y
Retrovirology; 2009 Feb; 6():19. PubMed ID: 19228429
[TBL] [Abstract][Full Text] [Related]
16. Quantitative proviral DNA and antibody levels in the natural history of HTLV-I infection.
Manns A; Miley WJ; Wilks RJ; Morgan OS; Hanchard B; Wharfe G; Cranston B; Maloney E; Welles SL; Blattner WA; Waters D
J Infect Dis; 1999 Nov; 180(5):1487-93. PubMed ID: 10515807
[TBL] [Abstract][Full Text] [Related]
17. HLA-B*35 as a new marker for susceptibility to human T-cell lymphotropic virus type 1 (HTLV-1) Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP) in patients living in Argentina.
Benencio P; Fraile Gonzalez SA; Ducasa N; Page K; Berini CA; Biglione MM
Retrovirology; 2020 Sep; 17(1):29. PubMed ID: 32883310
[TBL] [Abstract][Full Text] [Related]
18. Pathogenesis and prevention of HTLV-1-associated diseases.
Miwa M; Kushida S; Maeda N; Fang J; Kawamura T; Kameyama T; Uchida K
Leukemia; 1997 Apr; 11 Suppl 3():65-6. PubMed ID: 9209300
[TBL] [Abstract][Full Text] [Related]
19. Health state utility values in people living with HTLV-1 and in patients with HAM/TSP: The impact of a neglected disease on the quality of life.
Rosadas C; Assone T; Yamashita M; Adonis A; Puccioni-Sohler M; Santos M; Paiva A; Casseb J; Oliveira ACP; Taylor GP
PLoS Negl Trop Dis; 2020 Oct; 14(10):e0008761. PubMed ID: 33064742
[TBL] [Abstract][Full Text] [Related]
20. Quantitative differences in HTLV-I antibody responses: classification and relative risk assessment for asymptomatic carriers and ATL and HAM/TSP patients from Jamaica.
Enose-Akahata Y; Abrams A; Johnson KR; Maloney EM; Jacobson S
Blood; 2012 Mar; 119(12):2829-36. PubMed ID: 22318200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]